CANADA PENSION PLAN INVESTMENT BOARD
PensionPosition in LYEL — Lyell Immunopharma, Inc.
CIK 1283718
TORONTO ONTARIO, A6
Position in LYEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$589,984
-$398,392 QoQ
Shares Held
29,411
-8.4% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CANADA PENSION PLAN INVESTMENT BOARD holds $702,821,582 across 110 Biotechnology names. LYEL ranks #51 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
187,553 | $144,910,949 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
190,051 | $84,865,373 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
208,938 | $69,131,316 | |
| 4 | INCY |
Incyte Corp
|
607,944 | $57,219,689 | |
| 5 | SANA |
Sana Biotechnology, Inc.
|
10,221,900 | $29,439,072 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
1,242,800 | $27,043,328 | |
| 7 | BNTX |
BioNTech SE
|
303,508 | $26,975,791 | |
| 8 | CAI |
Caris Life Sciences, Inc.
|
1,322,752 | $23,650,805 |
All Filings in LYEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $589,984 | 29,411 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $988,376 | 32,111 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $477,634 | 29,411 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $259,993 | 29,411 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||